feed,title,long_url,short_url
MedRxiv,Prediction and evolution of the molecular fitness of SARS-CoV-2 variants: Introducing SpikePro,https://biorxiv.org/cgi/content/short/2021.04.11.439322v1?rss=1,https://j.mp/3g4K52f
MedRxiv,Revealing the threat of emerging SARS-CoV-2 mutations to antibody therapies,https://biorxiv.org/cgi/content/short/2021.04.12.439473v1?rss=1,https://j.mp/2OJjlsP
MedRxiv,Combinatorial approach with mass spectrometry and lectin microarray dissected glycoproteomic features of virion-derived spike protein of SARS-CoV-2,https://biorxiv.org/cgi/content/short/2021.04.10.439300v1?rss=1,https://j.mp/3a46A3e
MedRxiv,Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351,https://biorxiv.org/cgi/content/short/2021.04.11.439360v1?rss=1,https://j.mp/3ddTfYe
